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ABSTRACT 
The interruption of DNA binding is a gateway to the inhibition of unregulated 
expression of genes which can possibly lead to illnesses such as cancer and epilepsy.  The 
goal of this research is to produce high affinity DNA binding molecules which could act 
to displace the binding of natural transcription factor thus reducing the over- or under-
expression of various proteins. Literature shows that the interruption of DNA binding can 
be completed using both organic and inorganic means, such as by means of natural 
transcription factors like the NF-κB protein or with metal-ligand complexes in order to 
bind DNA. NF-κB, a protein that plays a vital role in cell growth and immune response, 
works as a transcription factor and binds DNA using a beta sheet loop region. Mimics of 
the NF-κB binding region will be made and analyzed via circular dichroism and 
fluorescence. Metal ligand complexes are able to bind to DNA through two different 
interactions: intercalation into DNA via the ligand portion and ion coordination with the 
negatively charged phosphate backbones of DNA. The analysis of the metal complex 
binding affinity will be done using UV-Vis fluorescence spectroscopy, circular dichroism 
(CD) studies, and gel electrophoresis assays. The overall purpose of this research is to 
identify the more efficient binder with the higher affinity for DNA binding between 
organic and inorganic molecules. 
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Introduction  
The disruption of DNA binding is a gateway to the inhibition of expression of 
harmful genes which can possibly lead to illnesses such as cancer and epilepsy and as a 
result, artificial control of gene expression has been of interest in the medical field.6 The 
goal of this research is to achieve results, which could possibly lead to a better 
understanding of how DNA binds and eventually preventing binding in harmful strands. 
Literature shows that the interrupting of DNA binding can be done using both organic 
and inorganic means, such as using natural transcription factors like the NF-κB protein or 
using metals in complexes with ligand in order to bind DNA.6 In this research, the 
difference in affinity for DNA binding between organic and inorganic compounds will be 
compared and the more efficient binder will be the main focus of research.  
NF-κB is an important protein that plays a 
vital role in cell growth and immune response.3  
Working as a transcription factor, the protein binds 
directly to DNA and helps control the levels of 
transcription, thus gene expression. When the 
regulation of NF-κB is flawed, links to illnesses 
such as carcinogenesis and epilepsy have been 
discovered.7 The portion of the protein that makes 
the binding possible is the β-hairpin, or beta sheet 
loop region.3 The binding of the β-hairpin can be 
mimicked so that the binding is similar to that of the original β-hairpin but its purpose 
would be to block the binding of harmful DNA. A mimic of the structured β-hairpin 
Figure 1.  The binding of 
DNA via NF-κB. The figure 
depicts the two subunit in 
conjunction around the DNA 
while the β-hairpin region 
binds the DNA.3 
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found in the NF-κB will be used in binding studies such as fluorescence techniques like 
tryptophan quenching and could be completed in order to compare the binding affinity of 
the mimic to that of the original protein. The results of this experiment should analyze the 
ability of the mimic peptides to bind DNA as compared to NF-κB. Overall, if either 
mimic peptide is more successful in binding DNA than NF-κB, then the research could 
potentially be used in a clinical setting in order to prevent the overexpression of particular 
genes implicated in various diseases.  
Metal ligand complexes are becoming well studied 
molecules in the disruption of DNA binding. In fact, this 
technique has already been used in cancer treatment in 
which drugs such as cisplatin, which contains platinum, 
binds and damages DNA in order to prevent cell 
division.4 Metal ligand complexes are able to bind to 
DNA through two different interactions. The ligand 
portion has a planar heterocyclic structure and the 
aromatic portion is able to intercalate into the DNA, while 
the metal portion binds through ion coordination with the 
negatively charged phosphate backbones of DNA.1 For the 
focus of this research, metals of the lanthanides series will 
be used as the metal with ligand complexes, because they have been a recent interest due 
to their cytotoxicity as compared to drugs like cisplatin which use metals such as 
platinum.4 The analysis of the metal complexes’ binding affinities will be completed 
using circular dichroism (CD) studies and gel electrophoresis assays in which the 
Figure 2.  The binding of 
DNA via Metal-Ligand 
Complex. The figure depicts 
the ligand intercalating into the 
DNA, while the metal interacts 
with the phosphate backbone.2 
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expectation is that there will be a conformational change in the DNA as the metal-ligand 
complex binds the DNA. Multiple lanthanide metals will be used in order to determine 
the one with the highest binding affinity.  
Overall, the goal of this research is to determine the binding affinity of the 
synthesized DNA binding molecules, with the goal that they will have a higher affinity 
and displace natural transcription factors. If successful, this research could be used in 
order to prevent the over- or under-expression of genes by these transcription factors.  
 
Methods 
Peptide Design 
 
Figure 3. NF-κB Hybrid Structure. The sequence for the peptide mimic was based on the 
binding site of the original NF-κB protein and is as follows:  
Gln-Arg-Phe-Arg-Trp-Val-Arg-Val-Asn-Gly-Lys-Tyr-Ile-Lys-Val-Gln-Leu-Glu 
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Metal-Ligand Complexes 
 
Figure 4. Gd-Ligand Complex. The molecular formula is as follows: 
[Gd III (NO3)2 (H2O) (pyr)2]. The other complexes (Tb, Dy, Er, and Ho) have the same 
structure with the central metal atom being varied for each.  
  
Peptide Synthesis  
 For each peptide, CLEAR amide resin was employed to synthesize the peptide 
using a 0.1 mmol scale, with each amino acid coupled onto the resin with four 
equivalents of HBTU, a coupling reagent. Dimethylformamide was the solvent for all 
peptide synthesis. A 20% piperidine solution in DMF was utilized to deprotect the Fmoc 
protecting group from each amino acid. Coupling times of about 60 minutes and 
deprotection times of 20 minutes were employed. The order sequence was then run in a 
Protein Technologies PS3 peptide synthesizer coupling from the C terminal to the N 
terminal amino acid. The last eight amino acids were double coupled and an acetic 
anhydride capping solution was added to cap the N-terminal of the peptide.   
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Cleavage 
 In order to cleavage the peptide from the resin on which it was synthesized, a 
cleavage reaction had to be conducted. To dry the resin, dichloromethane was used along 
with nitrogen gas to agitate the sample. The cleavage cocktail was composed of 95% 
trifluoroacetic acid (TFA), 2.5% tri-isopropalsilane (TIPS), and 2.5 water, and this was 
allowed to react with the peptide in a cleavage flask for two hours. The resulting solution 
was then drained into a round bottom flask which was then treated with air until enough 
TFA had evaporated and only a dime-sized amount remained. Then 20 mL of ether and 
20 mL of water was added to the flask in order to allow the peptide to precipitate out of 
the solution. The final solution was then allowed to separate in a separatory funnel. The 
various layers were collected then frozen in liquid nitrogen, followed by three days on the 
lyophilizer, resulting in peptides in power form.   
 
Dissolution  
 The dissolution of the peptide was necessary for the purification using 
chromatography. Various solutions were used in order to attempt dissolution. If 
unsuccessful, the samples were lyophilized, then dissolved in other solutions.  
 
Purification  
 Using High-Performance Liquid Chromatography (HPLC), the peptide was 
purified using a peptide method which was composed of a gradient using first Solvent A 
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(95% HPLC Grade Water, 5% Acetonitrile, 0.1% trifluoroacetic acid), then Solvent B 
(95% Acetonitrile, 5% HPLC Grade Water, 0.1% trifluoroacetic acid), with increasing 
Solvent B from 0% to 40% over 25 minutes, regardless of the method. In order to analyze 
a peptide, 40 microliters was injected. The peaks were collected based on absorbance, 
and these peaks contained the peptides produced in the sythesis.  
 
Mass Spectrometry 
 A Microflex MALDI-ToF MS (mass spectrometry) was performed in order to 
analyze the purified peptide collected from the HPLC. All fractions were analyzed with a 
matrix composed of α-cyano-4-hydroxycinnamic acid in standard solution (50% 
acetonitrile, 47.5% DI water, and 2.75% trifluoroacetic acid).   
 
Circular Dichroism  
A. NF-κB  Hybrid 
Circular dichroism was performed in order to analyze the secondary structure of 
the peptide mimics. The samples were prepared using 50µL of peptide with 200µL of 10 
mM Na2HPO4, 100 mM NaCl, pH 7.2. Peptides were analyzed at temperature 25ºC with 
a wavelength range of 190-260nm. 
B. Metal-Ligand Complexes 
Circular dichroism titrations were performed in order to detect if there were 
changes in secondary structure of the 250 ng/µL calf thymus DNA upon metal complex 
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binding. The samples were prepared using 70 µL of calf thymus DNA with 200 µL of 10 
mM Na2HPO4 pH 7.4. The metal-ligand complexes were titrated into the DNA using 1µL 
aliquots. All titrations were completed at 25ºC from 220-340nm. 
 
UV-Vis Fluorescence Binding Study  
 A binding study was conducted using UV-vis fluorescence. Each sample was 
prepared with a consistent peptide concentration (8 µM), an increasing DNA 
concentration (0-60 µM), and 10 mM Na2HPO4, 100 mM NaCl, pH 7.3. Total sample 
volume was equal to 800 µL with 20 samples total. The parameters were the following: 
Slit width in 5, out 2.5, wavelength 300-500 nm. The excitation wavelength was set to 
297 nm and the emission was 348 nm.  
 
 
Results 
NF-κB Hybrid Peptide Data 
Mass Spectrometry 
 Using MALDI-ToF, mass spectrometry was completed in order to verify the 
peptide’s mass after the synthesis, cleavage, and purification. The purification process 
involved desalting the peptide using a desalting column in order to remove any salts from 
the peptide. Mass spectrometry identified the peptide fraction which correlated to the 
theoretical mass. The data shown in Figure 5 shows a highly purified peptide with the 
experimental value of 2361.93. NF-κB Hybrid has a theoretical mass of 2360.25.  
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Figure 5. Mass spectrometry of NF-κB Hybrid Fractions 2, 3. The graph shows a high 
peak at 2361.93 and expected mass is 2360.25.  
 
Circular Dichroism Analysis 
Circular dichroism was completed on the peptide mimic, NF-κB Hybrid, in order to 
determine the secondary structure. NF-κB Hybrid has the desired structure of the NF-κB 
protein binding site, a β-sheet, as shown by the 210 nm minimum, and some random coil, 
as shown by the minimum at 195 nm. This secondary structure could be an indicator to 
the binding capability of NF-κB Hybrid. Previous research has shown that structured 
peptides bind single stranded DNA better that unstructured peptides.8 This study will 
investigate if this is true for a dsDNA binding by transcription factors.  
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Figure 6. Circular dichroism spectrum of NF-κB Hybrid that shows two minima which 
indicate a β-sheet (210 nm) with random coil (195nm). The sample was analyzed at 25ºC 
from 190-260 nm in 10 mM Na2HPO4, 100 mM NaCl, and pH 7.2 
 
Fluorescence DNA Binding Study 
Fluorescence binding studies were completed in duplicate on NF-κB Hybrid using 
various DNA sequences. The concentrations of the peptide and DNA were determined 
using UV-vis (Table 1) and were used to calculate volumes for each sample analyzed. 
The peptide concentration was kept constant at 8 μM, while the DNA concentration 
increased from 0-60 μM (Tables 2, 3, and 4). When the peptide binds DNA, the spectra 
shows a decrease. As the DNA concentration increases, there is a greater shift in the 
spectra, as shown by Figures 7 and 8.  
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Table 1. Fluorescence stock stock solution concentrations in the three trials with NF-κB 
Hybrid using three different DNA sequences: κB, Unmethylated, and Methylated. 
 Trial 1 Trial 2 Trial 3 
Peptide 
Concentration 
395 μM 339 μM 228 μM 
DNA Concentration 685 μM 575 μM 732  μM 
DNA Sequence 
κB Sequence Unmethylated Methylated  
5’-GGAGTGTCCC-3’ 5’-GTATCCGGATAC-3’  5’-GTATC/Me-dC/GGATAC-3’ 
3’-CCTCACAGGG-5’ 3’-CATAGGCCTATG-5’ 3’-CATAGGC/Me-dC/TATG-5’ 
 
 
Table 2. Fraction concentrations for the fluorescence binding study of NF-κB Hybrid and 
the κB DNA sequence. Each fraction was run in duplicate in the study. 
Fluorescence Concentration Chart 
Sample  Buffer (μL) Peptide (8μM) DNA (μM) DNA (μL) 
1 779 21 0 0 
2 777 21 2 2 
3 773 21 5 6 
4 767 21 10 12 
5 761 21 15 18 
6 756 21 20 23 
7 750 21 25 29 
8 744 21 30 35 
9 732 21 40 47 
10 709 21 60 70 
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Table 3. Fraction concentrations for the fluorescence binding study of NF-κB Hybrid and 
the Unmethylated DNA sequence. Each fraction was run in duplicate in the study. 
Fluorescence Concentration Chart 
Sample  Buffer (μL) Peptide (8μM) DNA (μM) DNA (μL) 
1 781 19 0 0 
2 778 19 2 3 
3 774 19 5 7 
4 767 19 10 14 
5 760 19 15 21 
6 753 19 20 28 
7 746 19 25 35 
8 739 19 30 42 
9 725 19 40 56 
10 698 19 60 83 
 
Table 4. Fraction concentrations for the fluorescence binding study of NF-κB Hybrid and 
the Methylated DNA sequence. Each fraction was run in duplicate in the study. 
Fluorescence Concentration Chart 
Sample  Buffer (μL) Peptide (8μM) DNA (μM) DNA (μL) 
1 772 28 0 0 
2 770 28 2 2 
3 767 28 5 5 
4 761 28 10 11 
5 756 28 15 16 
6 750 28 20 22 
7 745 28 25 27 
8 739 28 30 33 
9 728 28 40 44 
10 706 28 60 66 
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Figure 7. Fluorescence binding study which shows the binding activity between 8 μM 
NF-κB Hybrid and 0-60 μM kB DNA, sequence found in Table 1. The experiment was 
completed using 10 mM Na2HPO4, 100 mM NaCl, and pH 7.3. 
 
 
Figure 8. Fluorescence binding study which shows the binding activity between 8 μM 
NF-κB Hybrid and 0-60 μM Unmethylated DNA, sequence found in Table 1. The 
experiment was completed using 10 mM Na2HPO4, 100 mM NaCl, and pH 7.3. 
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Figure 9. Fluorescence binding study which shows the binding activity between 8 μM 
NF-κB Hybrid and 0-60 μM Methylated DNA, sequence found in Table 1. The 
experiment was completed using 10 mM Na2HPO4, 100 mM NaCl, and pH 7.3. 
 
 
Metal-Ligand Complexes Data 
 The metal-ligand complexes were analyzed using circular dichroism in order to 
identify binding between the metal-ligand complex and calf thymus DNA. When binding 
occurred, there was an apparent shift down in the spectra showing a change in the 
structure of the DNA. The initial shift in CD spectra indicated the binding affinity of each 
metal-ligand complex.  
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Figure 10. CD Titration of 3 mM Gd-Ligand Complex in 250 ng/µL Calf Thymus DNA 
showing a decrease in the DNA signal, which indicates binding activity.  
 
Figure 11. CD Titration of 3 mM Tb-Ligand Complex in 250 ng/µL Calf Thymus DNA 
showing a decrease in the DNA signal, which indicates binding activity.  
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Figure 12. CD Titration of 3 mM Dy-Ligand Complex in 250 ng/µL Calf Thymus DNA 
showing a decrease in the DNA signal, which indicates binding activity.  
 
Figure 13. CD Titration of 3 mM Ho-Ligand Complex in 250 ng/µL Calf Thymus DNA 
showing a decrease in the DNA signal, which indicates binding activity.  
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Figure 13. CD Titration of 3 mM Er-Ligand Complex in 250 ng/µL Calf Thymus DNA 
showing a decrease in the DNA signal, which indicates binding activity.  
 
Discussion and Conclusion 
 Binding studies are an important method in which DNA binding molecules can be 
analyzed. The binding studies conducted within this research have shown that various 
DNA binding molecules can be analyzed using different methods and provide fruitful 
results. The fluorescence binding study shows that the NF-κB Hybrid is successful at 
binding the κB sequence and a methylated DNA sequence as well. The CD titration 
analysis showed that the lanthanide metal-ligand complexes successfully bind calf 
thymus DNA.   
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There is an abundance of future work which can be completed with this data. To 
start, more NF-κB mimics could be synthesized with different binding sequences in order 
to determine if there are more peptide mimics which can bind selectively. Additionally, 
the dissociation constant, Kd, can be found for the peptide mimics in order to be 
compared to the known Kd of the NF-κB protein. The metal-ligand complexes could be 
further analyzed by completing a gel electrophoresis assay. In the assays, the desired 
result will be a decrease in the amount of relaxed and supercoiled DNA in comparison to 
the control as the metal-ligand complex binds. Overall, this research explores the 
possibility that altering the expression of genes with organic and inorganic compounds 
can one day leads to a decrease in some diseases.  
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